tiprankstipranks
Trending News
More News >
Cross Country Healthcare (CCRN)
NASDAQ:CCRN
US Market

Cross Country Healthcare (CCRN) Ratios

Compare
265 Followers

Cross Country Healthcare Ratios

CCRN's free cash flow for Q4 2025 was $0.13. For the 2025 fiscal year, CCRN's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.78 3.78 2.78 2.79 2.49
Quick Ratio
3.78 3.78 2.78 2.79 2.45
Cash Ratio
1.40 1.40 0.68 0.12 0.01
Solvency Ratio
-0.62 -0.62 0.02 0.44 0.40
Operating Cash Flow Ratio
0.62 0.62 1.00 1.67 0.49
Short-Term Operating Cash Flow Coverage
41.49 41.49 0.00 0.00 0.00
Net Current Asset Value
$ 167.46M$ 167.46M$ 164.71M$ 209.23M$ 185.05M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.17
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.35
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.26
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.25
Financial Leverage Ratio
1.39 1.39 1.41 1.43 2.07
Debt Service Coverage Ratio
0.59 0.59 8.51 12.24 14.80
Interest Coverage Ratio
-1.56 -1.56 -7.71 13.93 18.75
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.15
Interest Debt Per Share
0.14 0.14 0.18 0.38 4.65
Net Debt to EBITDA
-7.98 -7.98 -4.64 -0.09 0.55
Profitability Margins
Gross Profit Margin
18.66%18.66%20.41%22.30%22.28%
EBIT Margin
-0.33%-0.33%-0.05%5.50%9.54%
EBITDA Margin
1.26%1.26%1.25%6.40%9.99%
Operating Profit Margin
-0.33%-0.33%-1.25%5.58%9.63%
Pretax Profit Margin
-7.92%-7.92%-1.22%5.09%9.03%
Net Profit Margin
-9.00%-9.00%-1.08%3.60%6.63%
Continuous Operations Profit Margin
-9.00%-9.00%-1.08%3.60%6.63%
Net Income Per EBT
113.58%113.58%88.77%70.59%73.48%
EBT Per EBIT
2412.19%2412.19%97.23%91.29%93.78%
Return on Assets (ROA)
-21.13%-21.13%-2.47%10.69%19.62%
Return on Equity (ROE)
-24.30%-29.38%-3.47%15.34%40.68%
Return on Capital Employed (ROCE)
-0.93%-0.93%-3.60%21.24%39.91%
Return on Invested Capital (ROIC)
-0.93%-0.93%-3.18%14.92%29.15%
Return on Tangible Assets
-26.53%-26.53%-3.53%14.84%25.14%
Earnings Yield
-32.10%-36.13%-2.40%9.12%18.91%
Efficiency Ratios
Receivables Turnover
6.29 6.29 5.53 5.20 4.25
Payables Turnover
18.63 18.63 186.24 516.22 169.39
Inventory Turnover
0.00 0.00 0.00 0.00 196.88
Fixed Asset Turnover
35.17 35.17 42.91 67.46 122.33
Asset Turnover
2.35 2.35 2.28 2.97 2.96
Working Capital Turnover Ratio
4.96 4.90 5.59 6.02 7.87
Cash Conversion Cycle
38.40 38.40 64.00 69.47 85.63
Days of Sales Outstanding
57.99 57.99 65.96 70.18 85.93
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 1.85
Days of Payables Outstanding
19.59 19.59 1.96 0.71 2.15
Operating Cycle
57.99 57.99 65.96 70.18 87.78
Cash Flow Ratios
Operating Cash Flow Per Share
1.49 1.49 3.60 7.07 3.62
Free Cash Flow Per Share
1.24 1.24 3.34 6.67 3.38
CapEx Per Share
0.25 0.25 0.26 0.40 0.24
Free Cash Flow to Operating Cash Flow
0.83 0.83 0.93 0.94 0.93
Dividend Paid and CapEx Coverage Ratio
5.91 5.91 13.78 17.78 15.26
Capital Expenditure Coverage Ratio
5.91 5.91 13.78 17.78 15.26
Operating Cash Flow Coverage Ratio
20.82 20.82 31.03 47.18 0.85
Operating Cash Flow to Sales Ratio
0.05 0.05 0.09 0.12 0.05
Free Cash Flow Yield
13.39%15.27%18.38%29.46%12.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.12 -2.77 -41.64 10.96 5.29
Price-to-Sales (P/S) Ratio
0.28 0.25 0.45 0.39 0.35
Price-to-Book (P/B) Ratio
0.92 0.81 1.45 1.68 2.15
Price-to-Free Cash Flow (P/FCF) Ratio
7.47 6.55 5.44 3.39 7.85
Price-to-Operating Cash Flow Ratio
6.12 5.44 5.05 3.20 7.34
Price-to-Earnings Growth (PEG) Ratio
<0.01 >-0.01 0.34 -0.18 0.13
Price-to-Fair Value
0.92 0.81 1.45 1.68 2.15
Enterprise Value Multiple
14.48 11.71 31.50 6.06 4.06
Enterprise Value
193.01M 156.09M 528.40M 784.15M 1.14B
EV to EBITDA
14.48 11.71 31.50 6.06 4.06
EV to Sales
0.18 0.15 0.39 0.39 0.41
EV to Free Cash Flow
4.81 3.89 4.74 3.34 9.08
EV to Operating Cash Flow
4.00 3.24 4.40 3.16 8.49
Tangible Book Value Per Share
7.16 7.14 7.24 8.06 6.73
Shareholders’ Equity Per Share
9.98 9.96 12.55 13.46 12.35
Tax and Other Ratios
Effective Tax Rate
-0.14 -0.14 0.11 0.29 0.27
Revenue Per Share
32.61 32.53 40.26 57.45 75.74
Net Income Per Share
-2.93 -2.93 -0.44 2.07 5.02
Tax Burden
1.14 1.14 0.89 0.71 0.73
Interest Burden
24.12 24.12 22.62 0.93 0.95
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.18 0.15 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
-4.05 0.00 -8.25 3.42 0.72
Currency in USD